Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CHINA SHENGHUO PHARMACEUTICAL Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
IONIS PHARMACEUTICALS | 53,56 | -2,08 % | FDA grants breakthrough therapy status to Ionis ION582 to treat Angelman syndrome | ||
SINOPHARM | 2,020 | -1,51 % | Aktie der Sinopharm Group heute am Aktienmarkt kaum gefragt: Kurs fällt (2,012 €) | Im Wertpapierhandel notiert das Wertpapier der Sinopharm Group derzeit leichter. Das Wertpapier notiert zur Stunde bei 2,01 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 09.09.2025 Ein Minus... ► Artikel lesen | |
INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
CSPC PHARMA | 1,213 | +1,29 % | CSPC Pharmaceutical Group-Aktie mit deutlichen Kursgewinnen (1,221 €) | Zu den großen Gewinnern an der Börse zählt am Mittwoch der Anteilsschein der CSPC Pharmaceutical Group . Der Kurs des Anteilsscheins legt kräftig zu. Ein Wertanstieg auf zwischenzeitlich 1,22 Euro beschert... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 1,941 | -2,14 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,580 | -1,50 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification | - Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the... ► Artikel lesen | |
ACADIA PHARMACEUTICALS | 20,670 | +1,62 % | Assessing ACADIA Pharmaceuticals: Insights From 12 Financial Analysts | ||
MADRIGAL PHARMACEUTICALS | 371,60 | +1,12 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
METRIOPHARM | - | - | MetrioPharm gains orphan drug status from EMA for MP1032 | ||
CATALYST PHARMACEUTICALS | 17,000 | +0,77 % | Catalyst Pharmaceuticals auf Baird-Konferenz: Strategischer Fokus auf Wachstum bei seltenen Krankheiten | ||
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings amends, converts 8% debentures | ||
NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness reports Q3 results |